Five core clock genes, CRY2, DBP, PER2, RORA, and PER3, have significant prognostic value in at least two databases, while CRY2 and DBP have prognostic effects in all three databases (Figure 6D), suggesting that they are potential prognostic biomarkers for pan-RCC. This evidence concerns the gene RORA and renal cell carcinoma.